Search research articles
Contact Us
Filters
Showing results (81-90 of 119) with videos related to
Page
of 12
Sort By:
Journal of Medicinal Chemistry
|
October 1, 1988
Benzo[1,2-c:5,4-c']dipyrazoles: non-xanthine adenosine antagonists
N P Peet, G A Dickerson, A H Abdallah, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 1, 1996
A palliative accelerated irradiation regimen (PAIR) for advanced non-small-cell lung cancer (NSCLC)
U Nestle, C Nieder, U Abel, et al.
Pneumologie (Stuttgart, Germany)
|
August 16, 2001
[Accuracy of positron emission tomography with fluorine-18-fluoro-deoxyglucose]
D Hellwig, A Gröschel, K Rentz, et al.
Seminars in Oncology
|
October 1, 1994
Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents
U Bruntsch, S Drechsler, J Eggert, et al.
Pneumologie (Stuttgart, Germany)
|
April 29, 1998
[Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma]
M Hoefer, S Schmidt, J Welter, et al.
Journal of Medicinal Chemistry
|
September 1, 1986
N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors
R A Olsson, S Kusachi, R D Thompson, et al.
Nuklearmedizin. Nuclear Medicine
|
November 7, 2002
[Optimization of radiotherapy planning for non-small cell lung cancer (NSCLC) using 18FDG-PET]
S Schmidt, U Nestle, K Walter, et al.
FEBS Letters
|
February 15, 1988
Radioligand binding of antagonists of platelet-activating factor to intact human platelets
D Ukena, G Dent, F W Birke, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 5, 2000
A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 GY: results of a randomized equivalence study
U Nestle, C Nieder, K Walter, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Tolerance, safety, and kinetics of the new antineoplastic compound dexniguldipine-HCl after oral administration: a phase I dose-escalation trial
D Ukena, C Boewer, B Oldenkott, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 119) with videos related to
Sort By:
Page
of 12
Journal of Medicinal Chemistry
|
October 1, 1988
Benzo[1,2-c:5,4-c']dipyrazoles: non-xanthine adenosine antagonists
N P Peet, G A Dickerson, A H Abdallah, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 1, 1996
A palliative accelerated irradiation regimen (PAIR) for advanced non-small-cell lung cancer (NSCLC)
U Nestle, C Nieder, U Abel, et al.
Pneumologie (Stuttgart, Germany)
|
August 16, 2001
[Accuracy of positron emission tomography with fluorine-18-fluoro-deoxyglucose]
D Hellwig, A Gröschel, K Rentz, et al.
Seminars in Oncology
|
October 1, 1994
Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents
U Bruntsch, S Drechsler, J Eggert, et al.
Pneumologie (Stuttgart, Germany)
|
April 29, 1998
[Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma]
M Hoefer, S Schmidt, J Welter, et al.
Journal of Medicinal Chemistry
|
September 1, 1986
N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors
R A Olsson, S Kusachi, R D Thompson, et al.
Nuklearmedizin. Nuclear Medicine
|
November 7, 2002
[Optimization of radiotherapy planning for non-small cell lung cancer (NSCLC) using 18FDG-PET]
S Schmidt, U Nestle, K Walter, et al.
FEBS Letters
|
February 15, 1988
Radioligand binding of antagonists of platelet-activating factor to intact human platelets
D Ukena, G Dent, F W Birke, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 5, 2000
A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 GY: results of a randomized equivalence study
U Nestle, C Nieder, K Walter, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Tolerance, safety, and kinetics of the new antineoplastic compound dexniguldipine-HCl after oral administration: a phase I dose-escalation trial
D Ukena, C Boewer, B Oldenkott, et al.
Page
of 12